FDA Approves New Prostate Cancer Imaging Agent Gozellix®
Gozellix®, after radiolabeling with 68 Ga, is indicated for PET scanning of PSMA positive lesions in men with prostate cancer who have suspected metastasis and are candidates for initial definitive ...
EQS-News: Heidelberg Pharma announces financial figures and reports on successful business performance in 2024
Ladenburg, Germany, 21 March 2025 – Heidelberg Pharma AG (FSE: HPHA) today published its financial results and Annual Report for fiscal year 2024 (1 December 2023 – 30 November 2024) and its outlook ...
Casper Star-Tribune21h
FDA Increases Testing For Heavy Metals In Baby Formula
THURSDAY, March 20, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) is stepping up testing for heavy ...